In recent days, antipyretics for children of nimesulide as a However, many pharmacies have panic the face of this storm, the shelves are still full spectrum Hong Chi Pharmaceutical
behind Johnson
directed at children, antipyretics at home on the market to Nimesulide is the main component, Pharmaceutical aspects of health, said Chi, compared with Merrill Lynch, Rui Zhiqing to price advantage, Yu Hongjiang
chairman, said in an interview, over the past decade, our country does not nimesulide communication of information related adverse reactions, Rui Zhiqing listed nine years, it is produce satisfactory results. The mastermind behind the event, Johnson is likely to be multinationals.
the possibility of speculation to be traced back to November 26 last year, the name of security warning message, saying that Subsequently, Johnson appeared on the official website disabled
present, Hong Chi Commerce and Industry Bureau of Hainan has been submitted to distorted and exaggerated, deliberately fueled, malicious compete against rivals and other bad behavior.
to prove his innocence, Hong Chi has to communicate with the FDA is willing to Ruizhi Qing and Merrill Lynch, a drug safety evaluation comparison, for scientific evaluation.
Johnson has yet to
Food and Drug Administration experts: the cause of death from improper use rather than the drugs themselves
onto the cusp of Lee Nimesulide is still the SFDA approval, to allow for children's fever medicine. In addition, the National Adverse Drug Reaction Centre is organizing its security experts for further argument. Guangdong Food and Drug Administration also said the province were monitored between 9 to 133 cases of adverse reactions, but no cases of liver damage children.
It is understood that, in June 2008, the SFDA had to modify the instructions of nimesulide on the indications, usage, dosage, contraindications, precautions and so the a revised, more specifically to remind the drug only for children over 1 year old, a dose of 5mg/kg body weight / day in 2-3 divided doses, maximum dose of no more than 100mg, 1 day 2 times daily for not more than 3 days.
rational use of Ministry of Health expert Professor Sun Zhongshi monitoring system that a few years ago, the international medical community and pharmaceutical worlds have for the safety of Nimesulide debate, but In recent years, the existing domestic and international clinical research literature, including a 40 million large sample of clinical studies have shown that nimesulide and other non-steroidal anti-inflammatory drugs such as ibuprofen, acetaminophen, and other similar Compared drugs, antipyretic analgesic effect equivalent to a considerable adverse reaction.
Professor Sun that the National Adverse Drug Reaction Monitoring Center to collect the vast majority of adverse drug reactions, drug quality is not the problem, but with the improper use of drugs. Several children's deaths, child deaths and did not find Hong Chi
incident triggered a sharp drop
experts share the positive interpretation of the parties have not dispel doubts on the matter bad news after another.
reporter from the European Medicines Agency, Department of Health, Hong Kong, China and other foreign authorities learned that nimesulide not only not recommended for use by children, their legal offshore the only pain medication, antipyretics not, the EU also prohibited fever, flu patients.
indeed affect the body, overnight, and was sought after by many institutions become institutions Kang Chi Pharmaceutical Antipyretics day of the accident, Kang Chi Pharmaceutical shares to 64.5 yuan from the morning sharply lower open, share prices will be down quickly, and repeatedly hit daily limit. Strongly suppress short of funds under the Hong Chi Pharmaceutical plunged 8.49% to close at the end,
fact, this is not the first time Hong Chi Pharmaceutical heavy volume drops, contrarian . February 14 this year, a media report Kang Chi Pharmaceutical Products Nimesulide caused 20 cases of liver damage, its main business or crises, the company despite the emergency suspension, and at noon to be clarified, but the stock still plummeted after resumption of trading , single-day drop to 5.02%, turnover reached 209 million, compared to the previous average daily turnover of about 30 million yuan a huge increase.
voices of doubt in the public opinion in Hong Chi Pharmaceutical next two trading days the share price remained low, the minimum has dropped to 64.8 yuan, while ultra-February 17 or rebound, but the Feb. 18 fell 3.7% again. According to report statistics, in February 14 to 18 weeks time, the GEM that rose to 2.7%, and 138 stocks in the sector to achieve higher, while Hong Chi Pharmaceutical has plunged 8.17%.
According to the Shenzhen Stock Exchange publicly traded information display, yesterday, five institutions to sell medicine in Hong seats in the top five in Chicago, the cumulative amount to 207 million sold , representing the total amount of shares traded throughout the day 36.19%. Hong Chi Pharmaceutical day if the average price of 59.93 yuan to calculate the transaction, the five institutions to sell shares to 345.46 million shares actually! According to the Hong Chi Pharmaceutical three quarterly in 2010 showed that the circulation of shareholders holding more than 70 million shares, only five funds.
main products in the former crisis, Hong Chi medicine has always been a institutions are buying 42,789,200 yuan and 17.1862 million yuan, institutions will rush to raise significantly, and in the May 28, 2010 and January 25 this year, two seats in the transaction list, there were large-scale institutional buying seats Zhi Kang medicine. In addition, shareholders in its circulation list of agencies can be found in favor of Hong Chi Pharmaceutical a plus. Statistics, as of September 30, 2010, Hong Chi Pharmaceutical top 10 tradable shareholders are fund companies, of which 122 million shares held by the social security portfolio 603, the second largest shareholders of circulation for the stock, while the rich countries, Yinhua other fund companies also rank the list of top 10 tradable shareholders.
No comments:
Post a Comment